Imperial College London
Portrait Picture

ProfessorMohamedShamji

Faculty of Medicine, National Heart & Lung Institute

Professor of Immunology and Allergy
 
 
 
//

Contact

 

+44 (0)20 7594 3476m.shamji99 Website

 
 
//

Location

 

Room 111Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Agache:2020:10.1111/all.14235,
author = {Agache, I and Rocha, C and Beltran, J and Song, Y and Posso, M and Sola, I and Alonso-Coello, P and Akdis, C and Akdis, M and Canonica, GW and Casale, T and Chivato, T and Corren, J and Del, Giacco S and Eiwegger, T and Firinu, D and Gern, JE and Hamelmann, E and Hanania, N and Makela, M and Martin, IH and Nair, P and O'Mahony, L and Papadopoulos, NG and Papi, A and Park, H-S and Perez, de Llano L and Quirce, S and Sastre, J and Shamji, M and Schwarze, J and Canelo-Aybar, C and Palomares, O and Jutel, M},
doi = {10.1111/all.14235},
journal = {ALLERGY},
pages = {1043--1057},
title = {Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma},
url = {http://dx.doi.org/10.1111/all.14235},
volume = {75},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Agache,I
AU  - Rocha,C
AU  - Beltran,J
AU  - Song,Y
AU  - Posso,M
AU  - Sola,I
AU  - Alonso-Coello,P
AU  - Akdis,C
AU  - Akdis,M
AU  - Canonica,GW
AU  - Casale,T
AU  - Chivato,T
AU  - Corren,J
AU  - Del,Giacco S
AU  - Eiwegger,T
AU  - Firinu,D
AU  - Gern,JE
AU  - Hamelmann,E
AU  - Hanania,N
AU  - Makela,M
AU  - Martin,IH
AU  - Nair,P
AU  - O'Mahony,L
AU  - Papadopoulos,NG
AU  - Papi,A
AU  - Park,H-S
AU  - Perez,de Llano L
AU  - Quirce,S
AU  - Sastre,J
AU  - Shamji,M
AU  - Schwarze,J
AU  - Canelo-Aybar,C
AU  - Palomares,O
AU  - Jutel,M
DO  - 10.1111/all.14235
EP  - 1057
PY  - 2020///
SN  - 0105-4538
SP  - 1043
TI  - Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
T2  - ALLERGY
UR  - http://dx.doi.org/10.1111/all.14235
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000533436100004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 75
ER  -
Download